UOTTAIMCU
NVO

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Novo Nordisk NVO Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,684
Closed -$439K – 190
2024
Q3 		$439K Sell
3,684
-1,415
-28% -$189K 0.07% 81
2024
Q2 		$728K Buy
+5,099
New +$676K 0.14% 74

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s NVO Position: Q4 2024 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 3,684 shares — an estimated $439K sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in NVO in Q2 2024 and held it in 2 quarters. The position peaked at $728K in Q2 2024. 1,665 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 3,684 Novo Nordisk shares in Q4 2024, an estimated $439K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Novo Nordisk in Q2 2024 and held it in 2 quarters.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Novo Nordisk position peaked at $728K in Q2 2024.
  • 1,665 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q4 2024, filed 19 Feb 2025.